THE UNIVERSITY OF TEXAS LUNG CANCER SPORE: ADMINSTRATIVE CORE A RESPONSIBILITIES (University of Texas Southwestern Medical Center and The University of Texas MD Anderson Cancer Center) 1. Responsibility for the overall scientific quality assurance and function of the SPORE, the Scientific Projects and the Core Resources. Communicate and consult with Project Investigators and Core leaders including Developmental and Career Development Project Investigators. Ensure communication, cooperation, and integration between activities at the two different University of Texas sites (UT Southwestern and UT M.D. Anderson Cancer Center). Encourage institutional commitment to the SPORE Program. 2. Responsibility for overall compliance with all general Governmental and specific NCI regulations and requirements. Communicate and consult frequently with the NCI Project Officer and other staff, and be responsible for the preparation of all necessary reports and other reporting requirements. 3. Coordinate data quality control and quality assurance issues in conjunction with the Internal Review and Monitoring Committees of UTSW and MDACC and the Biostatistics and Bioinformatics Cores C and D. 4. Oversee expenditures and maintain budget information. 5. Convene all necessary meetings, including the Executive Committee, External and Internal Advisory Committees, monthly scientific videoconference meetings, lectures, symposia, and attendance at the annual SPORE and the Lung Cancer SPORE meetings. 6. Administer the Developmental Research and Career Development Programs including obtaining mentors, biostatistical, and bioinformatics support and assist the Executive Committee and External Advisors in selection of projects for funding of Developmental and Career Development Projects. Specifically establish and monitor policies for recruitment of women and minorities to this program. 7. Assist with preparation of all publications resulting from the SPORE program. 8. Coordinate, obtain and maintain Institutional commitment to the SPORE at UTSW and MDACC. 9. Encourage and facilitate inter SPORE communication, collaborations, cooperation, data and resource sharing. 10. Coordinate and facilitate SPORE interactions with the PHARMA and Biotech industry 11. Coordinate and facilitate Patient Advocate involvement in the SPORE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA070907-15W1
Application #
8731339
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
2013-09-12
Project End
2014-08-31
Budget Start
2013-09-12
Budget End
2014-08-31
Support Year
15
Fiscal Year
2013
Total Cost
$75,485
Indirect Cost
$18,486
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Tu, Huakang; Heymach, John V; Wen, Chi-Pang et al. (2016) Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S. Sci Rep 6:26760
Jafri, Mohammad A; Ansari, Shakeel A; Alqahtani, Mohammed H et al. (2016) Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med 8:69
Tong, Pan; Diao, Lixia; Shen, Li et al. (2016) Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis. Cancer Inform 15:81-9
Hao, Chuncheng; Shao, Ruping; Raju, Uma et al. (2016) Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistance. Oncotarget 7:38235-38242
Guijarro-Muñoz, Irene; Roarty, Emily B; Heymach, John V (2016) Bevacizumab beyond disease progression for advanced non-small cell lung cancer: Does persistence have its rewards? Cancer 122:1047-9
Schabath, M B; Welsh, E A; Fulp, W J et al. (2016) Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene 35:3209-16
Kundu, S T; Byers, L A; Peng, D H et al. (2016) The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene 35:173-86
Mak, Milena P; Tong, Pan; Diao, Lixia et al. (2016) A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition. Clin Cancer Res 22:609-20
Bendris, Nawal; Stearns, Carrie J S; Reis, Carlos R et al. (2016) Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells. J Cell Sci 129:2804-16
Hensley, Christopher T; Faubert, Brandon; Yuan, Qing et al. (2016) Metabolic Heterogeneity in Human Lung Tumors. Cell 164:681-94

Showing the most recent 10 out of 908 publications